Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout price provides investors with sufficient cash for their shares. 

On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share in cash.  Following the closing of the proposed transaction, SEM shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.        

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their SEM shares.  Notably, at the time the proposed transaction was announced, at least one stock analyst was maintaining a price target for Select Medical’s shares of $19.00 per share.  

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their Select Medical shares, and whether the company’s representatives breached their fiduciary duties in agreeing to the $16.50 per share buyout price.   

Select Medical investors who would like to learn more about the investigation and their legal rights and options are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 – 0750, by email at [email protected], or by completing the form on this page.